However, it is not FDA-approved for medical treatment or injection, and regulatory status may vary by use
Ipamorelin: The Pinnacle of Targeted Selectivity As science progressed, researchers identified the side effects of GHRP-6 and asked a vital question: Can we create a peptide that delivers the anti-aging benefits of growth hormone, without the appetite stimulation, cortisol spikes, and prolactin elevations
Regulatory status As of June 2026, tesamorelin is FDA-approved only for HIV-associated lipodystrophy (EGRIFTA WR / EGRIFTA SV)
Considering the main causes of the development of T2DM, impaired insulin secretion and insulin resistance, the apparent inefficiency of current pharmaceutical strategies may be due to the undue focus place on alleviating symptoms, such as hyperglycemia by stimulating insulin secretion
Yatmaz S, Seow HJ, Gualano RC, et al